Hims & Hers Health (HIMS) Share-based Compensation Growth (1y) (2021 - 2026)
Hims & Hers Health (HIMS) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 26.47% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 47.06% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 8.79% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 281.05% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 92.83% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 5.49% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 61.54% |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | 52.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.49% |
| Dec 31, 2025 | 107.62% |
| Sep 30, 2025 | 217.81% |
| Jun 30, 2025 | 973.35% |
| Mar 31, 2025 | 35.09% |
| Dec 31, 2024 | 241.70% |
| Sep 30, 2024 | 135.55% |
| Jun 30, 2024 | -89.52% |
| Dec 31, 2023 | 119.41% |
| Sep 30, 2023 | -377.08% |
| Jun 30, 2023 | 62.50% |
| Dec 31, 2022 | 40.60% |
| Sep 30, 2022 | -7.50% |
| Jun 30, 2022 | 108.34% |
| Mar 31, 2022 | -98.82% |
| Dec 31, 2021 | -4,627.67% |
| Sep 30, 2021 | 4,784.36% |
| Jun 30, 2021 | 195.87% |
| Mar 31, 2021 | 2,338.03% |